ODDB.org: Open Drug Database | Drugs

		Product	Registr. Holder	Package Size	Composition	CP	%	SB
IP	CI	Lansoprazol-Teva 30 mg	Teva Pharma AG	28 Capsule(s)		27.75		k.A.
IP	CI	Lansoprazol-Teva 30 mg	Teva Pharma AG	56 Capsule(s)		43.70	-21%	k.A.
IP	CI	Lansoprazol Sandoz 30	Sandoz Pharmaceuticals AG	56 Capsule(s)	Capsules: Lansoprazolum 30 mg	44.55	-19%	10 %
IP	CI	Lansoprazol-Mepha 30	Mepha Pharma AG	56 Capsule(s)	Capsules: Lansoprazolum 30 mg	44.55	-19%	10 %
IP	CI	Agopton 30 mg	Takeda Pharma AG	56 Capsule(s)	magensaftresistente Hartkapseln: Lansoprazolum 30 mg	52.80	-4%	20 %
IP	CI	Lansoprazol-Teva 30 mg	Teva Pharma AG	14 Capsule(s)		15.95	+14%	k.A.
IP	CI	Lansoprazol Sandoz 30	Sandoz Pharmaceuticals AG	28 Capsule(s)	Capsules: Lansoprazolum 30 mg	33.20	+19%	10 %
IP	CI	Lansoprazol-Mepha 30	Mepha Pharma AG	28 Capsule(s)	Capsules: Lansoprazolum 30 mg	33.20	+19%	10 %
IP	CI	Agopton 30 mg	Takeda Pharma AG	28 Capsule(s)	magensaftresistente Hartkapseln: Lansoprazolum 30 mg	36.15	+30%	20 %
IP	CI	Lansoprazol Sandoz 30 ‐ I	Sandoz Pharmaceuticals AG	14 Capsule(s)	Capsules: Lansoprazolum 30 mg	26.00	+87%	10 %
IP	CI	Lansoprazol-Mepha 30	Mepha Pharma AG	14 Capsule(s)	Capsules: Lansoprazolum 30 mg	26.00	+87%	10 %
IP	CI	Agopton 30 mg	Takeda Pharma AG	14 Capsule(s)	magensaftresistente Hartkapseln: Lansoprazolum 30 mg	26.75	+92%	20 %

For price comparison between Original and Generic please click onto the name of the drug all the way to the left!

show caption

2025	©ywesee GmbH